ArticleCancer immunology, immunotherapy : CII2015

Anti-PD-L1 prolongs survival and triggers T cell but not humoral anti-tumor immune responses in a human MUC1-expressing preclinical ovarian cancer model.

Jyothi Thyagabhavan Mony et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.